456 related articles for article (PubMed ID: 10516675)
21. Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.
Jantunen E; Canals C; Rambaldi A; Ossenkoppele G; Allione B; Blaise D; Conde E; Tilly H; Cook G; Clark F; Gallamini A; Haynes A; Mounier N; Dreger P; Pfreundschuh M; Sureda A;
Haematologica; 2008 Dec; 93(12):1837-42. PubMed ID: 18838474
[TBL] [Abstract][Full Text] [Related]
22. Second autologous stem cell transplant for multiply relapsed Hodgkin's disease.
Lin TS; Avalos BR; Penza SL; Marcucci G; Elder PJ; Copelan EA
Bone Marrow Transplant; 2002 May; 29(9):763-7. PubMed ID: 12040474
[TBL] [Abstract][Full Text] [Related]
23. Autologous hematopoietic stem cell transplantation for severe autoimmune disease with special reference to rheumatoid arthritis.
Tyndall A;
J Rheumatol Suppl; 2001 Oct; 64():5-7. PubMed ID: 11642506
[TBL] [Abstract][Full Text] [Related]
24. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
25. Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation.
Stewart DA; Guo D; Glück S; Morris D; Chaudhry A; deMetz C; Klassen J; Brown CB; Russell JA
Bone Marrow Transplant; 2000 Aug; 26(4):383-8. PubMed ID: 10982284
[TBL] [Abstract][Full Text] [Related]
26. Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation.
Villela L; Sureda A; Canals C; Sanz MA; Martino R; Valcárcel D; Altés A; Briones J; Gómez M; Brunet S; Sierra J
Haematologica; 2003 Mar; 88(3):300-5. PubMed ID: 12651269
[TBL] [Abstract][Full Text] [Related]
27. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
[TBL] [Abstract][Full Text] [Related]
29. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
30. Autologous stem cell transplantation for high-risk Hodgkin's disease: improvement over time and impact of conditioning regimen.
Subirà M; Sureda A; Martino R; García J; Altés A; Canals C; Domingo-Albós A; Brunet S; Sierra J
Haematologica; 2000 Feb; 85(2):167-72. PubMed ID: 10681724
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic stem cell transplants for autoimmune disease: role of EULAR. European League Against Rheumatism.
van de Putte LB; Tyndall A; van den Hoogen FH; Smolen JS
J Rheumatol Suppl; 1997 May; 48():98-9. PubMed ID: 9150128
[TBL] [Abstract][Full Text] [Related]
33. Collection of hematopoietic stem cells from patients with autoimmune diseases.
Burt RK; Fassas A; Snowden J; van Laar JM; Kozak T; Wulffraat NM; Nash RA; Dunbar CE; Arnold R; Prentice G; Bingham S; Marmont AM; McSweeney PA
Bone Marrow Transplant; 2001 Jul; 28(1):1-12. PubMed ID: 11498738
[TBL] [Abstract][Full Text] [Related]
34. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1998 Aug; 22(3):227-40. PubMed ID: 9720735
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
[TBL] [Abstract][Full Text] [Related]
36. Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications.
Marmont AM
Best Pract Res Clin Haematol; 2004 Jun; 17(2):223-32. PubMed ID: 15302336
[TBL] [Abstract][Full Text] [Related]
37. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Majhail NS; Weisdorf DJ; Defor TE; Miller JS; McGlave PB; Slungaard A; Arora M; Ramsay NK; Orchard PJ; MacMillan ML; Burns LJ
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1065-72. PubMed ID: 17084370
[TBL] [Abstract][Full Text] [Related]
38. Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.
Corradini P; Dodero A; Zallio F; Caracciolo D; Casini M; Bregni M; Narni F; Patriarca F; Boccadoro M; Benedetti F; Rambaldi A; Gianni AM; Tarella C
J Clin Oncol; 2004 Jun; 22(11):2172-6. PubMed ID: 15169805
[TBL] [Abstract][Full Text] [Related]
39. Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma.
Kewalramani T; Nimer SD; Zelenetz AD; Malhotra S; Qin J; Yahalom J; Moskowitz CH
Bone Marrow Transplant; 2003 Oct; 32(7):673-9. PubMed ID: 13130314
[TBL] [Abstract][Full Text] [Related]
40. Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation.
Kahl C; Leithäuser M; Wolff D; Steiner B; Hartung G; Casper J; Freund M
Ann Hematol; 2002 Nov; 81(11):646-50. PubMed ID: 12454703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]